Treatment With Pazopanib for Neoadjuvant Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: doxorubicin + cyclophosphamide|DRUG: paclitaxel + pazopanib|PROCEDURE: surgery|DRUG: pazopanib monotherapy
Sponsor: GlaxoSmithKline
Collaborators: NSABP Foundation Inc